Showing results (1251-1260 of 1,432) with videos related to

Sort By:
Pageof 144
Plos One|March 4, 2016
Depression, Stressful Life Events, and the Impact of Variation in the Serotonin Transporter: Findings from the National Longitudinal Study of Adolescent to Adult Health (Add Health)Brett C Haberstick, Jason D Boardman, Brandon Wagner, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Total integrated performance excellence system (TIPES): A true north direction for a clinical trial support centerMike R Sather, Sherry Parsons, Kathy D Boardman, et al.
Journal of Medical Screening|May 19, 2026
No-cost envelope modification improves fecal immunochemical test laboratory acceptance in a US Veterans Affairs colorectal cancer screening trialJason A Dominitz, Douglas J Robertson, Sophie Miller, et al.
Social Science & Medicine (1982)|October 22, 2022
Benefits and harms adopted by health economic assessments evaluating antenatal and newborn screening programmes in OECD countries: A systematic review of 336 articles and reportsMay Ee Png, Miaoqing Yang, Sian Taylor-Phillips, et al.
Cell Death & Disease|October 17, 2014
HDAC8 and STAT3 repress BMF gene activity in colon cancer cellsY Kang, H Nian, P Rajendran, et al.
Transplantation and Cellular Therapy|January 24, 2024
A Positive Psychology Intervention for Caregivers of Hematopoietic Stem Cell Transplantation Survivors (PATH-C): Initial Testing and Single-Arm Pilot TrialHermioni L Amonoo, Michelle Guo, Annabella C Boardman, et al.
World Journal of Gastroenterology|March 2, 2018
Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancerMohamad A Mouchli, Lidia Ouk, Marianne R Scheitel, et al.
Developmental Cognitive Neuroscience|April 9, 2026
Neonatal amygdala microstructure and structural connectivity are associated with autistic traits at 2 years of ageKadi Vaher, Samuel R Neal, Manuel Blesa Cábez, et al.
Cancer Treatment and Research|January 5, 2002
EGF/ErbB receptor family in ovarian cancerN J Maihle, A T Baron, B A Barrette, et al.
Cell Death and Differentiation|October 24, 2015
DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53S K Alam, V K Yadav, S Bajaj, et al.
Pageof 144